Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fidelity® NASDAQ Composite Index® Tracking Stock Fund (ONEQ)

185.72
Delayed Data
As of Jun 24
 -6.95 / -3.61%
Today’s Change
141.00
Today|||52-Week Range
205.63
-5.63%
Year-to-Date

Investment Objective

The investment seeks to provide investment returns that closely correspond to the price and yield performance of the Nasdaq Composite Index . The fund normally invests at least 80% of assets in common stocks included in the index. It uses statistical sampling techniques that take into account such factors as capitalization, industry exposures, dividend yield, price/earnings (P/E) ratio, price/book (P/B) ratio, and earnings growth to create a portfolio of securities listed in the Nasdaq Composite Index that have a similar investment profile to the entire index.

No recent news for Fidelity® NASDAQ Composite Index® Tracking Stock Fund.

Performance

1 month-3.07% 3 years+13.62%
3 months-0.98% 5 years+13.41%
1 year-6.84% Since inception+8.58%
Data through 06/25/2016

Quote Details

Previous close$192.67
Open day’s range184.46 – 188.66
Net asset value (NAV)185.10 (06/24/2016)
Daily volume88,459
Average volume (3 months)17,015
Data as of 4:00pm ET, 06/24/2016

Peer Comparisonvs. Large growth ETFs

 ONEQCategory
Performance 5-yr return+13.41%+12.72%
Expense Gross exp ratio0.31%0.42%
Risk 5 year sharpe ratio0.930.95
Net assets$643.5M$3.4B
Average market cap$32.5B$88.6B
Average P/E20.224.6
Dividend / Share--0.17%

Competitors

VOOG Vanguard S&P 500 Growth Index Fund ETF S...
SPYG SPDR® S&P 500 Growth ETF
IVW iShares S&P 500 Growth ETF

Holdings

Top 5 Sectors
Portfolio weighting
Hardware 20.56%
Telecommunication 14.30%
Healthcare 12.17%
Consumer service 10.32%
Financial service 7.19%
Top 10 Holdings
Portfolio weighting
AAPL Apple7.21%
MSFT Microsoft5.47%
AMZN Amazon4.31%
FB Facebook3.74%
GOOG Google3.32%
GOOGL Google2.87%
CMCSA Comcast2.05%
INTC Intel1.98%
CSCO Cisco1.91%
GILD Gilead Sciences1.67%

Partner Offers